Geneva Capital Management LLC increased its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 11.2% in the 3rd quarter, Holdings Channel reports. The firm owned 535,742 shares of the company’s stock after buying an additional 53,810 shares during the period. Geneva Capital Management LLC’s holdings in Ryan Specialty were worth $30,194,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in RYAN. Principal Financial Group Inc. grew its position in Ryan Specialty by 21.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,392,717 shares of the company’s stock worth $247,576,000 after purchasing an additional 765,428 shares during the period. Montrusco Bolton Investments Inc. boosted its stake in shares of Ryan Specialty by 23.7% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 3,974,869 shares of the company’s stock worth $217,745,000 after buying an additional 762,638 shares during the last quarter. Champlain Investment Partners LLC grew its holdings in shares of Ryan Specialty by 76.9% in the third quarter. Champlain Investment Partners LLC now owns 3,066,011 shares of the company’s stock worth $172,800,000 after acquiring an additional 1,332,773 shares during the period. Geode Capital Management LLC grew its holdings in shares of Ryan Specialty by 3.9% in the second quarter. Geode Capital Management LLC now owns 2,018,275 shares of the company’s stock worth $137,244,000 after acquiring an additional 75,598 shares during the period. Finally, Invesco Ltd. increased its position in Ryan Specialty by 17.3% during the second quarter. Invesco Ltd. now owns 1,865,325 shares of the company’s stock valued at $126,823,000 after acquiring an additional 274,463 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.
Wall Street Analyst Weigh In
RYAN has been the topic of a number of recent research reports. JPMorgan Chase & Co. lowered their target price on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating on the stock in a report on Wednesday, January 7th. Barclays reduced their price target on shares of Ryan Specialty from $58.00 to $52.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Zacks Research downgraded shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 24th. UBS Group reduced their target price on shares of Ryan Specialty from $71.00 to $65.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Finally, Cantor Fitzgerald decreased their price target on shares of Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $56.87.
Ryan Specialty Stock Down 3.8%
RYAN stock opened at $36.40 on Wednesday. The business’s 50-day moving average price is $45.57 and its 200-day moving average price is $51.56. The stock has a market cap of $9.62 billion, a P/E ratio of 86.66, a PEG ratio of 0.99 and a beta of 0.65. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty Holdings Inc. has a twelve month low of $36.38 and a twelve month high of $77.16.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million for the quarter, compared to analysts’ expectations of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The firm’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.45 EPS. On average, equities research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.
Ryan Specialty Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 24th were paid a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.4%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date of this dividend was Tuesday, February 24th. Ryan Specialty’s dividend payout ratio is currently 123.81%.
Insider Activity
In related news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the company’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. This trade represents a 6.33% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, CEO Timothy William Turner sold 129,570 shares of Ryan Specialty stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the completion of the sale, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. This trade represents a 91.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 52.21% of the company’s stock.
Ryan Specialty Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Read More
- Five stocks we like better than Ryan Specialty
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
